Effectiveness of Docetaxel and Gemcitabine in Lung Cancer
Author Information
Author(s): W Zoli, L Ricotti, M Susino Dal, F Barzanti, G L Frassineti, S Folli, A Tesei, F Bacci, D Amadori
Primary Institution: Divisione di Oncologia Medica, Ospedale ‘GB Morgagni-L Pierantoni’
Hypothesis
The study investigates the activity of docetaxel and gemcitabine in NSCLC cell lines and primary cultures.
Conclusion
Docetaxel and gemcitabine show strong synergistic effects when administered in a specific sequence with a 48-hour washout period.
Supporting Evidence
- Docetaxel and gemcitabine were the most active drugs tested.
- The sequence of drug administration affected the level of synergy observed.
- Sequential treatment with a 48-hour washout showed strong synergistic effects in primary cultures.
Takeaway
This study tested two cancer drugs to see how well they work together, and found that taking them in a certain order can make them more effective.
Methodology
The study evaluated the cytotoxic activity of various drugs using the sulphorhodamine B assay and flow cytometric analysis.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website